GLMoat Dive
Glanbia plc GLAPF Moat
Glanbia's sports nutrition margin fell from 16.9% to 13.0% in one year on record whey costs.
A single external customer supplies $402.9M of that segment's revenue, roughly 22% of the whole of it.
Key data
The moat
Optimum Nutrition is the brand a gym-goer names when asked about protein powder, which in a category where the underlying commodity is identical across every tub is the entire advantage. Whey is whey. The buyer pays for the label, the flavour consistency and the belief that the stated protein content is the actual protein content.
The ingredients business is a different moat: nutritional premixes formulated into a food manufacturer's own product, where the formulation is written into the customer's specification and reformulating means requalifying the product.
What the brand should produce is the ability to pass raw material costs through, because a name the buyer asks for by name should survive a fifty cent price rise.
Widening or narrowing
The branded half lost margin and the ingredients half gained it.
| Measure | FY2024 | FY2025 | Q1 2026, like for like |
|---|---|---|---|
| Performance nutrition revenue | $1.81B | $1.80B | +11.5% |
| Performance nutrition margin | 16.9% | 13.0% | not disclosed |
| Health and nutrition margin | 17.6% | 18.4% | not disclosed |
| Health and nutrition revenue growth | +11.6% | ||
| Group revenue | $3.84B | $3.95B | +7.2% |
The branded segment lost 3.9 points of margin in a single year, which the company attributes to record whey input costs. Revenue was flat, so the cost was absorbed rather than passed on.
The ingredients segment gained 0.8 points over the same year. It sells to manufacturers, on contracts, with formulation lock-in, and it held price while the consumer brand did not. The unglamorous half of the company turned out to have the better moat.
The most recent quarter shows a sharp reacceleration: group revenue up 7.2% like for like, the branded segment up 11.5%, and the flagship brand up 18.8%. That is one quarter and the margin is not disclosed alongside it.
The overrated case, and it is the pass-through failure. A brand that cannot raise its price when its input cost rises is not exercising pricing power, it is holding volume. Losing nearly four points of margin on flat revenue is the clearest evidence in this analysis of a brand being tested and not passing.
The concentration compounds it. One external customer accounts for $402.9M of branded revenue, roughly 22% of the segment, and one customer supplies $405.6M of the ingredients segment, about 27%. A brand whose reach to the consumer runs through a single retailer at that scale is negotiating with that retailer, not with the shopper.
On profit pool, Glanbia takes a manufacturer's margin on a commodity it packages and names. The retailer between it and the buyer takes a share of the same tub and, at 22% of the segment, has the leverage.
The moat is narrowing.
Inside the complete Moat Dive
- 01What breaks it, and who
- 02Closing
- 03Methodology
Continue with GLAPF
Get the complete Moat Dive free.
Choose this as your free complete report. No card required.
Read the complete reportAlready a member? Sign in
